Ludwig Cancer Research gives $90 million to MIT
MIT is one of six institutions receiving a total of $540 million to provide reliable, long-term support for high-impact, innovative research.
MIT is one of six institutions receiving a total of $540 million to provide reliable, long-term support for high-impact, innovative research.
Shifts in zinc’s location could be exploited for early diagnosis of prostate cancer.
Five-year grant will support research on cancer therapy, artificial tissue homeostasis, and infectious diseases.
Drugs that block new target gene could make many tumors more vulnerable to chemotherapy.
Chemists develop new way to kill cancer cells resistant to the chemotherapy drug cisplatin.
New nanoparticles weaken tumor-cell defenses, then strike with chemotherapy drug.
Particles that deliver vaccines directly to mucosal surfaces could defend against many infectious diseases.
A microfluidic platform provides a high-resolution view of a crucial step in cancer metastasis.
New findings could lead to drugs that fight back when tumors don’t respond to treatment.
New technology offers three-dimensional images, making it easier to detect precancerous lesions.
New research enables high-speed customization of novel nanoparticles for drug delivery and other uses.
David Benjamin will investigate mechanisms that melanoma cells use to spread to distant sites throughout the body
Findings may offer a new way to kill cancer cells by forcing them into an alternative programmed-death pathway.
New study measures physical changes in tumor cells as they become metastatic.
Drugs that block nitric oxide could weaken cancer cells’ resistance, researchers say.